Boston Scientific Corporation
Large Cap · Healthcare · Medical Devices
$51.52−$0.31 (-0.60%)
Boston Scientific Corporation
Large Cap · Healthcare · Medical Devices
$51.52−$0.31 (-0.60%)
Stock analysis
Get the AI take on BSX
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$42.20
High$109.50
Today $51.52
RSI (14)
72.3Overbought
03070100
Overall score
73/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Lowest
$44
Current price
$51.52
Median target
$60
Highest
$94
LowHigh
Operating Record
Revenue
What's working
- Forward P/E: Investors aren't pricing in much earnings growth, so there's room to be pleasantly surprised.
- Debt / equity: Light borrowing means a rough patch wouldn't threaten the balance sheet.
What to watch
- Debt exceeds cash by $12.1B, increasing balance-sheet pressure, a warning sign.
What the market charges
Forward P/E
Favorable · 35% below avg
15.72x
Price / sales
Reasonable · Priced reasonably against its revenue
3.58x
Price / FCF
Reasonable · Priced a bit rich against its cash flow
20.72x
EV / EBITDA
Reasonable · Operating earnings make this price a stretch but plausible
15.27x
How efficiently it compounds
ROIC
Reasonable · A middling return on the capital it puts to work
11.2%
ROE
Middle ground · Mixed
15.3%
Debt / equity
Favorable · 0.43 - strong leverage
0.50x
Current ratio
Reasonable · Just enough on hand to cover near-term bills
1.24x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $75.11B | 21.0 | +13.5% | 73 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |